Thu, Jul 31, 2014, 11:06 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

CombiMatrix Corporation Message Board

pharmaapproved 331 posts  |  Last Activity: 4 hours ago Member since: Jun 7, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • If this has been posted in the past I apologize, but I just came across it and thought it was worth sharing for those who have not seen it. This is a 14 minute video of a Doctor from Kuwait who has performed this procedure numerous times. The video is in Arabic but does have a translation running on the bottom of the page. I must say after watching this I am a bigger believer then ever! If you haven't seen it's "A MUST SEE"

    youtubeDOTc0m/watch?v=Nd3CIeJNgt8

  • Reply to

    TARGET PRICE $ 14 PER SHARE....

    by adeiflig 12 hours ago
    pharmaapproved pharmaapproved 10 hours ago Flag

    Well hopefully management is smarter than what their being given credit for. If you listen to the last call which is still available on their website they made it clear what their objectives are.
    1. To create strategic partnership/s around the world in which ETRM would receive upfront money.
    2. They have surely been using the ATM recently and if not than I have a real problem with that.
    3. They have already stated they have enough cash to get through the approval process and beyond
    --------------------------------------------------------------------------------------------------------------------------------------------
    I really believe it won't be them (ETRM) bringing this to market. I believe they have put all there time and effort into approvals around the World setting the stage for a buy-out or WW partnership deal. The acquiring/partnering company would get an FDA approved devise (If approved of course) for a MULTI-BILLION dollar market. There may still even be a partner standing by for the countries already approved in for use. I believe ETRM is holding out for U.S. approval being it is the cream of the crop!

  • Reply to

    Share Offering 75 million shares at 85 cents???

    by adeiflig Jul 30, 2014 10:34 AM
    pharmaapproved pharmaapproved Jul 30, 2014 10:44 AM Flag

    LOL, BS why the complete 360 in your post? Did you sell and go short?

  • Reply to

    Wow - I never though we would see these levels

    by wisetobeme Jul 30, 2014 10:09 AM
    pharmaapproved pharmaapproved Jul 30, 2014 10:22 AM Flag

    I think the Street was blindsided by a positive recommendation. I was wrong though believing they wouldn't be able to push it down to this level. But they did and I can't help myself from pecking at it again today. I have not heard one legitimate argument as to why this will not be approved for use by the FDA. On the other hand there are many reasons to believe they will approve it. Weak and short term traders along with greedy tutes are to blame for what we have seen this week.

  • Reply to

    FINALLY: Business Update for August 7th + Earnings

    by adeiflig Jul 29, 2014 5:56 PM
    pharmaapproved pharmaapproved Jul 29, 2014 9:19 PM Flag

    Most of these questions have already been answered.

    a) When do you expect FDA Approval? I doubt they know but the FDA has noted by the EOY

    b) Once approved how are you going to market VBLOC? They already said through strategic partnerships, or a sales force headed up by the new marketing guy with WW experience. This question was answered on the last call

    c) Hiring employees, which markets targeted, advertising,number of clinics or doctors to visit? This was answered on the last call which is still available on their website

    d) Or, partnership discussions or buyout or, mergers or whatever? Strategic partnerships, Answered on the last call. They would never disclose buy-out or merger talks.

    e) How much money will it take for VBLOC to launch? Vaguely answered during the Q & A on the last call

    f) What other indications will VBLOC be used for? Plans for testing? Diabetes, answered on the last call

    g) Where is 24 month data? Vbloc group =21% EWL / Sham Group =3.9% EWL / Difference 17% thanks to Yahoo poster "zeeman" for this

    h) How much money was used on ATM to date? Good question

  • Reply to

    The War Has Just Started

    by grumpy_butt Jul 29, 2014 1:52 PM
    pharmaapproved pharmaapproved Jul 29, 2014 3:14 PM Flag

    I'm hunkering down with ya. I've been pecking at it all along and again today and will continue to do so. Almost acts like good or bad there is something out there floating around the average guy doesn't have access to. Could be good news, bad news, or weak holders stops being taken out. All I know is that right now at this very moment we are in a better place (Positive recommendation) than we where weeks ago. By the way albeit not by much short interest was down again at last report.

  • Reply to

    Free Fall

    by sguceri Jul 29, 2014 10:16 AM
    pharmaapproved pharmaapproved Jul 29, 2014 11:26 AM Flag

    There can only be one explanation in my view. If you have another I would love to hear it.

    ETRM has been committed to setting the stage for WW approval and have put all their time and resources into making this happen. The company will be sold or sign a WW partnership deal.

  • Reply to

    Free Fall

    by sguceri Jul 29, 2014 10:16 AM
    pharmaapproved pharmaapproved Jul 29, 2014 10:59 AM Flag

    I hate to see the downward pressure myself but ultimately believe it will be approved here in the U.S. Everyone needs to remember the devise is already approved in several other countries. ETRM has set themselves up for a WW partnership deal and U.S. approval will just be the icing on the cake!

    We heard from surgeons and folks in the field who spoke what I feel is loud and clear. They agreed the benefits outweigh the risk, the devise is safe, and could fill the gap in the race to cure the obesity epidemic in this country. Not to mention the Maestro devise has very similar results to both recently approved drugs Qysima & Belviq have.

    If this $1.40 level doesn't hold I would be prepared to add again in the mid $1.20 range. I really doubt they can push it down any further than that going into the decision. But the market will play it's game knowing they have time on there side for now. Until then it's all mind games.

  • Reply to

    Reality check

    by mario_themario Jul 28, 2014 12:11 PM
    pharmaapproved pharmaapproved Jul 28, 2014 1:03 PM Flag

    I think you just about covered it all in an unbiased observation. Jack has to go and it couldn't happen soon enough. All those claiming he sold because he's leaving at the end of the year is just a poor excuse. IF he is indeed stepping aside he should save what face he has left and do it now for the benefit of his shareholders. He has NO credibility on the "Street" he has lost all faith from shareholders, and with multiple blunders along the way from Arena and Eisai Belviq is struggling. The pipeline looks fine, and sounds wonderful but fact is it cost big bucks and Belviq is not paving the way. You can tell me all you want about future partnerships for new drugs and I will tell you it's years away. Those longs who are and where invested in Arena to this point have been so because of Belviq NOT the pipeline. You have guys like "Swalchie" claiming otherwise but why would anyone buy at $6 $7 $8 $9 if they knew it was going lower? MANAGEMENT SUXXXXS!!!

  • pharmaapproved pharmaapproved Jul 28, 2014 8:35 AM Flag

    I am in the camp who thinks silence is golden right now. There is no need for them to shoot themselves in the foot when they have things right where they want them for now. I was fine with the raises as it is common in bios when reaching milestones. I would also go out on a limb and suggest the ATM has been at work recently and is why we seen an insider purchase. I really believe we are so far off the radar we could see "Shock & Awe" very soon. Good luck!!!!

  • pharmaapproved pharmaapproved Jul 27, 2014 4:13 PM Flag

    "Last week the US National Institutes of Health unveiled a quarter-billion dollar project to speed the development of electroceuticals"

  • New article out today July 27,2014
    Tidbits from article

    "The excitement stems partly from the fact that unlike drugs implants can be very precisely targeted, with the impulses being applied just to miscreant cells, rather than the whole body. This should reduce the risk of side effects"
    -------------------------------------------------------------------------------------------------------------------
    "It also comes from some early successes using this technique. EnteroMedics, based in Minnesota, recently published the results of a study in which over 100 obese patients were fitted with an electroceutical implant that stimulates the vagus nerve, which affects both hunger and satiety the feeling of fullness that comes after a large meal.

    The study found that over half lost at least 20 per cent of their excess weight double the success rate achieved by patients in a comparison group. Blood pressure and heart rate also improved. Earlier this month, a panel of experts recommended that the US Food and Drug Administration approve this electroceutical for use in treating obesity"
    -------------------------------------------------------------------------------------------------------------------
    "Earlier this year the US Food and Drug Administration approved an electroceutical for treating sleep apnoea using an implant that delivers impulses to muscles to maintain steady breathing during sleep"

  • Reply to

    ARNA CC will announce Bel-Phen trial results

    by havenger2022 Jul 26, 2014 6:25 PM
    pharmaapproved pharmaapproved Jul 26, 2014 8:13 PM Flag

    They may as well. They already made a claim of 17% or somewhere along those lines. This was another one of their blunders but who counting. So if it holds true and the numbers are correct will it really be a surprise? I don't no being it's already out there.

  • pharmaapproved pharmaapproved Jul 24, 2014 10:02 AM Flag

    Exactly why this must be consumer driven. The patient actually has to want it and ask their Doctor for it by name in most cases. It used to drive me nuts when I would hear a Doctor talk to people about weight and yet they are as you say fat themselves. The patient can't take someone like that serious. Word of mouth and a MASSIVE consumer awareness campaign is what will make Belviq a success.

  • pharmaapproved pharmaapproved Jul 22, 2014 4:03 PM Flag

    Bad weather, seasonality, holidays, road construction ect..........

  • pharmaapproved pharmaapproved Jul 22, 2014 12:17 PM Flag

    He failed to persuade anyone. That may be him covering his short.

  • pharmaapproved pharmaapproved Jul 21, 2014 1:28 PM Flag

    We have all had our moments. With that said It would only be a victory for shorts and fudsters.

  • pharmaapproved pharmaapproved Jul 21, 2014 8:39 AM Flag

    In case you missed it scripts "could" explode.

  • pharmaapproved pharmaapproved Jul 21, 2014 8:16 AM Flag

    In Israel suffers from as well fifty percent of the adult population in the country is overweight or obese. The overweight rate is 50% higher among men

    Among Jewish men, the highest rates of obesity and overweight are in the 45-64 age group, where they reach 70% of the population. Sixty-four percent of Jewish women aged 65 and over are overweight or obese.

    Population: 7 Million

  • Management of Obesity in Adults being circulated to thousands of Family practice Doctors across the Country. Follow the link below for 33 pages of good stuff. All the drugs in the space mentioned in great detail.

    pceconsortiumDOTorg/Documents/ManagementObesityAdultsDOTpdf

CBMX
2.20-0.03(-1.35%)Jul 31 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Tesla Motors, Inc.
NasdaqGSThu, Jul 31, 2014 4:00 PM EDT
Expedia Inc.
NasdaqGSThu, Jul 31, 2014 4:00 PM EDT